The Finnish Allergy Program 2008-2018: Society-wide proactive program for change of management to mitigate allergy burden.


Journal

The Journal of allergy and clinical immunology
ISSN: 1097-6825
Titre abrégé: J Allergy Clin Immunol
Pays: United States
ID NLM: 1275002

Informations de publication

Date de publication:
08 2021
Historique:
received: 28 01 2021
revised: 03 03 2021
accepted: 24 03 2021
pubmed: 10 5 2021
medline: 21 10 2021
entrez: 9 5 2021
Statut: ppublish

Résumé

A 10-year national program to improve prevention and management of allergic diseases and asthma was implemented in Finland (population 5.5. million) in 2008-2018. The main aim was to reduce the long-term burden of these conditions. The strategy was changed from traditional avoidance to tolerance and resilience of the population. Health was endorsed instead of medicalization of mild symptoms. Disease severity was reevaluated, and disabling clinical manifestations were given high priority. For health care, 5 quantitative goals and 1 qualitative goal were set. For each of the goals, specific tasks, tools, and outcome evaluation were stipulated. During the program, 376 educational sessions gathered 24,000 health care participants. An information campaign targeted the lay public, and social media was used to contact people. In the 10 years of the program, the prevalence of allergic diseases and asthma leveled off. Asthma caused fewer symptoms and less disability, and 50% fewer hospital days. Food allergy diets in day care and schools decreased by half. Occupational allergies were reduced by 45%. In 2018, the direct and indirect costs of allergic diseases and asthma ranged from €1.5 billion to €1.8 billion, with the 2018 figures being 30% less than in the respective figures in 2007. The Finnish proactive and real-world intervention markedly reduced the public health burden of allergic disorders. The allergy paradigm was revisited to improve management with systematic education.

Identifiants

pubmed: 33965232
pii: S0091-6749(21)00559-5
doi: 10.1016/j.jaci.2021.03.037
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

319-326.e4

Investigateurs

Tari Haahtela (T)
Mika J Mäkelä (MJ)
Krista Abdulla Hama Salih (KA)
Peter Csonka (P)
Matti Hannuksela (M)
Paula Hellemaa (P)
Leena von Hertzen (L)
Juha Jantunen (J)
Paula Kauppi (P)
Tuula Ketola (T)
Tiina Laatikainen (T)
Irmli Lindström (I)
Miika Linna (M)
Soili Mäkinen-Kiljunen (S)
Anna Pelkonen (A)
Leena Petman (L)
Mervi Puolanne (M)
Ilkka Repo (I)
Kimmo Saarinen (K)
Alexander Salava (A)
Johannes Savolainen (J)
Erja Tommila (E)
Erkka Valovirta (E)
Tuula Vasankari (T)

Informations de copyright

Copyright © 2021 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Auteurs

Tari Haahtela (T)

Skin and Allergy Hospital, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. Electronic address: tari.haahtela@haahtela.fi.

Erkka Valovirta (E)

Department of Lung Diseases and Clinical Allergology, University of Turku, Turku, Finland; Allergy Clinic, Suomen Terveystalo Oy, Turku, Finland.

Kimmo Saarinen (K)

Allergy, Skin, and Asthma Federation, Helsinki, Finland.

Juha Jantunen (J)

Allergy, Skin, and Asthma Federation, Helsinki, Finland.

Irmeli Lindström (I)

Finnish Institute of Occupational Health, Helsinki, Finland.

Paula Kauppi (P)

Skin and Allergy Hospital, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.

Tiina Laatikainen (T)

Finnish Institute for Health and Welfare, Helsinki, Finland.

Anna Pelkonen (A)

Skin and Allergy Hospital, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.

Alexander Salava (A)

Skin and Allergy Hospital, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.

Erja Tommila (E)

Finnish Lung Health Association, Helsinki, Finland.

Jean Bousquet (J)

Charité, Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Comprehensive Allergy Center, Department of Dermatology and Allergy, Berlin, Germany; University Hospital, Montpellier, France; MACVIA France, Montpellier, France.

Tuula Vasankari (T)

Finnish Lung Health Association, Helsinki, Finland.

Mika J Mäkelä (MJ)

Skin and Allergy Hospital, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH